about
Common genes underlying asthma and COPD? Genome-wide analysis on the Dutch hypothesis.Sulfatase modifying factor 1 (SUMF1) is associated with Chronic Obstructive Pulmonary Disease.Susceptibility to COPD: differential proteomic profiling after acute smokingInflammation and corticosteroid responsiveness in ex-, current- and never-smoking asthmaticsSusceptibility to chronic mucus hypersecretion, a genome wide association study.Human Lung Tissue Transcriptome: Influence of Sex and Age.Glycogen synthase kinase-3β modulation of glucocorticoid responsiveness in COPD.Budesonide and fluticasone propionate differentially affect the airway epithelial barrierLatrophilin receptors: novel bronchodilator targets in asthmaThe asthma-COPD overlap syndrome: how is it defined and what are its clinical implications?Genetic variance is associated with susceptibility for cigarette smoke-induced DAMP release in mice.Pim1 kinase activity preserves airway epithelial integrity upon house dust mite exposure.Advanced glycation end products in the skin are enhanced in COPD.Combining genomewide association study and lung eQTL analysis provides evidence for novel genes associated with asthma.Bronchial Provocation Testing Can Be Improved by Using Dry Powder Adenosine Instead of Nebulized AMP.Small airway imaging phenotypes in biomass- and tobacco smoke-exposed patients with COPDA Potent Tartrate Resistant Acid Phosphatase Inhibitor to Study the Function of TRAP in Alveolar Macrophages.American Thoracic Society/National Heart, Lung, and Blood Institute Asthma-Chronic Obstructive Pulmonary Disease Overlap Workshop Report.Unmet needs for the assessment of small airways dysfunction in asthma: introduction to the ATLANTIS study.Quantification of free and total desmosine and isodesmosine in human urine by liquid chromatography tandem mass spectrometry: a comparison of the surrogate-analyte and the surrogate-matrix approach for quantitation.Less small airway dysfunction in asymptomatic bronchial hyperresponsiveness than in asthma.The Asthma COPD Overlap Syndrome: ACOS Epidemiology and Historical Perspective.Lung tissue gene-expression signature for the ageing lung in COPD.Viral mimic poly-(I:C) attenuates airway epithelial T-cell suppressive capacity: implications for asthma.The asthma-obesity relationship: underlying mechanisms and treatment implications.Tiotropium attenuates IL-13-induced goblet cell metaplasia of human airway epithelial cells.Effects of small airway dysfunction on the clinical expression of asthma: a focus on asthma symptoms and bronchial hyper-responsiveness.An airway epithelial IL-17A response signature identifies a steroid-unresponsive COPD patient subgroupAGER expression and alternative splicing in bronchial biopsies of smokers and never smokersQuality standards in respiratory real-life effectiveness research: the REal Life EVidence AssessmeNt Tool (RELEVANT): report from the Respiratory Effectiveness Group-European Academy of Allergy and Clinical Immunology Task ForceThe REal Life EVidence AssessmeNt Tool (RELEVANT): development of a novel quality assurance asset to rate observational comparative effectiveness research studiesFactors associated with hyperresponsiveness to adenosine 5'-monophosphate in healthy subjectsCharacterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolutionAuthor Correction: New genetic signals for lung function highlight pathways and chronic obstructive pulmonary disease associations across multiple ancestriesEffect of long-term corticosteroid treatment on microRNA and gene-expression profiles in COPDApplying the CAMP trial asthma remission prediction model to the Dutch asthma remission studiesExploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort studyDifferential lung tissue gene expression in males and females: implications for the susceptibility to develop COPDIntegrated proteogenomic approach identifying a protein signature of COPD and a new splice variant of SORBS1Finally More Direct Evidence That Impulse Oscillometry Measures Small Airway Disease
P50
Q30409688-BEEC1746-3E39-46AB-8C9F-93909ACF1151Q33630586-F2D1AD04-5C3A-4EC5-B5A9-828D3A34E023Q33921450-573A0664-7AF5-456E-A4EB-D3FB0BDC81E1Q34992972-232525FF-F163-40E1-BC19-CE9758BED556Q35143045-8F75ECCC-E20F-42FF-9429-D3D4E41AE122Q36208276-25E8C0C3-1C22-44DB-A8D4-47929D91CBEDQ36297783-B0A46E10-3609-4DDA-88FA-D0EEACF39472Q36439199-4300C3C8-288D-4050-A116-F19D4DB2290BQ37670533-445DC430-F624-4CB0-837F-C381AC0BB870Q38504195-D8C783C2-ED6E-47AB-AC57-21C715159DA0Q38700796-C1F4C4AE-9AA0-45F0-840D-B37279C946AAQ38829097-C7FC760B-A838-451E-9216-3434FCE714D1Q39158348-8CB092FC-4BD5-4113-972A-D89BF9A1C2D3Q39579831-75F0875E-31A1-492B-9D79-9B36A575F712Q40145677-3A09B6EA-9A70-4EB9-B7A7-0304EE6D550AQ41384495-B6E1137D-1063-469D-8D8D-2C1EB839DFDBQ42113583-F7F9A9D5-E002-4244-984E-CB8AF5DB8256Q43597554-456FDB23-2440-43D2-A6CA-08DF09BA2245Q43799793-258C245D-C5C8-4963-997A-0A984FBB4F14Q44295037-FE180D1E-8226-4E70-9BD0-8FD3AEED39F9Q44397687-FA1C3022-0E8B-49DC-808D-F245AE1F4350Q47105761-C3131C38-07F3-4685-9644-98D7F25A2D76Q47688217-CAD64989-E118-4F46-9982-BA75DB3AC3C8Q47996186-626B3959-6D52-444F-84A9-98F9080B53B6Q49617361-D935F2AF-2256-480B-91CD-7702D269B3BAQ51629607-5765AD71-CD2B-429F-B8B4-B705CD264368Q51703994-D951B095-D9C8-4B4F-B475-F3484A82C785Q58081543-A01C0A1F-6CBD-4A23-BDF4-2E265392CC77Q63432937-5046AACD-0B0A-4B85-8622-088E36A837A1Q64111015-1A6A0058-75D3-490C-9B5F-911A7E272C1FQ64111023-C0A581FE-D16A-40A1-9109-6EB03710746EQ91938739-57C400E4-8560-4A1E-861E-FD71E2750D47Q92028859-CB0CD9E4-2CB6-4C4F-A7F1-3B42A1EF5A79Q92174381-37B0679B-603C-4ACF-A065-9DB7BFAA26EAQ92205418-AC468B51-D10E-4961-99A6-460D5C1F25B5Q92399503-6C51DA48-A96E-4C00-A60B-B9BAE22EE42AQ92400307-FDC36406-181B-4BE1-B6EC-856E4542A4EFQ92524196-B026F6B2-5614-4A3B-B709-DF7ECC4060D3Q92641358-90D22000-76C9-48A2-A5CA-1181EB881678Q92682361-EE51C000-02CD-4653-8D37-C7DCFAFCDA0F
P50
description
researcher (ORCID 0000-0002-9336-7340)
@en
wetenschapper
@nl
name
Maarten van den Berge
@en
Maarten van den Berge
@nl
type
label
Maarten van den Berge
@en
Maarten van den Berge
@nl
prefLabel
Maarten van den Berge
@en
Maarten van den Berge
@nl
P31
P496
0000-0002-9336-7340